Correlation Between Edgewise Therapeutics and Psyence Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Psyence Biomedical Ltd, you can compare the effects of market volatilities on Edgewise Therapeutics and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Psyence Biomedical.

Diversification Opportunities for Edgewise Therapeutics and Psyence Biomedical

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Edgewise and Psyence is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Psyence Biomedical go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Psyence Biomedical

Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.27 times more return on investment than Psyence Biomedical. However, Edgewise Therapeutics is 3.67 times less risky than Psyence Biomedical. It trades about -0.05 of its potential returns per unit of risk. Psyence Biomedical Ltd is currently generating about -0.17 per unit of risk. If you would invest  3,400  in Edgewise Therapeutics on September 2, 2024 and sell it today you would lose (100.00) from holding Edgewise Therapeutics or give up 2.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  Psyence Biomedical Ltd

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Psyence Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Psyence Biomedical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Edgewise Therapeutics and Psyence Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and Psyence Biomedical

The main advantage of trading using opposite Edgewise Therapeutics and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.
The idea behind Edgewise Therapeutics and Psyence Biomedical Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.